Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

319
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
319
Pulmonary Function Tests01:25

Pulmonary Function Tests

1.1K
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

361
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
361
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

431
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiographic effects of a medetomidine-vatinoxan combination for sedating dogs without previously diagnosed heart disease.

Veterinary anaesthesia and analgesia·2026
Same author

Presence of <i>Dirofilaria immitis</i> in domestic cats and dogs in Chile: Assessment of monthly infection risk as a preventive tool.

Current research in parasitology & vector-borne diseases·2026
Same author

Retrospective analysis of carboxyhemoglobin and methemoglobin levels and their association with pneumonia severity in dogs.

Research in veterinary science·2026
Same author

Computed Tomography-Derived Bronchial Wall Indices in Cats with Clinical and Serological Features Compatible with Heartworm-Associated Respiratory Disease.

Animals : an open access journal from MDPI·2026
Same author

Deciphering the socio-environmental factors associated with realized heartworm transmission risk in dogs from Portugal and Spain.

Frontiers in veterinary science·2026
Same author

Characterization of Brachycephalic Obstructive Airway Syndrome in Cats Using Barometric Whole-Body Plethysmography.

Animals : an open access journal from MDPI·2026

Related Experiment Video

Updated: Apr 24, 2026

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

13.7K

Pulmonary function in obese vs non-obese cats.

Laín García-Guasch1, Alicia Caro-Vadillo2, Jordi Manubens-Grau1

  • 1Cardiology Service, Hospital Veterinari Molins, Barcelona, Spain.

Journal of Feline Medicine and Surgery
|September 12, 2014
PubMed
Summary

Obese cats show impaired pulmonary function, with decreased lung volumes and airflow. Barometric plethysmography revealed significant differences in breathing patterns between obese and normal-weight felines.

More Related Videos

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.3K
Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

17.5K

Related Experiment Videos

Last Updated: Apr 24, 2026

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

13.7K
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.3K
Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

17.5K

Area of Science:

  • Veterinary Medicine
  • Pulmonary Physiology
  • Comparative Medicine

Background:

  • Obesity is linked to respiratory issues in various species.
  • Reduced lung volumes and expiratory flow limitation are common in obese individuals.
  • Barometric whole-body plethysmography offers a non-invasive method to assess breathing dynamics.

Purpose of the Study:

  • To compare pulmonary function variables in obese versus non-obese cats.
  • To investigate the impact of feline obesity on respiratory mechanics.
  • To evaluate the utility of barometric plethysmography in assessing feline respiratory health.

Main Methods:

  • Utilized barometric whole-body plethysmography for dynamic breathing pattern analysis.
  • Recruited nine normal-weight and six obese cats for the study.
  • Measured key respiratory variables including tidal volume, minute volume, and peak flows per kilogram.

Main Results:

  • Obese cats exhibited significantly reduced tidal volume per kilogram (P = 0.003).
  • Minute volume per kilogram (P = 0.001) and peak inspiratory/expiratory flows per kilogram (P = 0.001) were also significantly lower in obese cats.
  • No significant increase in the bronchoconstriction index ( Penh) was observed in obese cats.

Conclusions:

  • Feline obesity negatively impacts pulmonary function, affecting lung volumes and airflow.
  • While obesity impairs respiratory mechanics, significant bronchoconstriction was not detected in this study.
  • Barometric whole-body plethysmography is a valuable tool for characterizing airway dysfunction in obese cats.